about
Integrated physiology and systems biology of PPARαMolecular Pathogenesis of NASHInhibitory effects of Japanese herbal medicines sho-saiko-to and juzen-taiho-to on nonalcoholic steatohepatitis in miceModel steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slicesIdentification of modulators of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) in a mouse liver gene expression compendiumChemical and Hormonal Effects on STAT5b-Dependent Sexual Dimorphism of the Liver TranscriptomeThe Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in MiceShugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPARα and L-FABP Expressions in High-Fat-Fed RatsHypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis.Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in miceMolecular pathways in non-alcoholic fatty liver disease.Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-α activation in cultured human female hepatocytes.GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes.Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse.Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.Nuciferine prevents hepatic steatosis and injury induced by a high-fat diet in hamsters.Choline and Fructooligosaccharide: Non-alcoholic Fatty Liver Disease, Cardiac Fat Deposition, and Oxidative Stress Markers.Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female miceNaturally improving insulin resistance with amorfrutins.Structural Correlates of PPAR Agonist Rescue of Experimental Chronic Alcohol-Induced SteatohepatitisPPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 peopleGenetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers.Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity.Alternating Diet as a Preventive and Therapeutic Intervention for High Fat Diet-induced Metabolic Disorder.High glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes.Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver diseasePentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidationCytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis.Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis.Cinnamic Acid and Its Derivatives: Mechanisms for Prevention and Management of Diabetes and Its Complications.Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice.c9,t11-Conjugated linoleic acid ameliorates steatosis by modulating mitochondrial uncoupling and Nrf2 pathway.The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury.Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.Selective peroxisome proliferator-activated receptor α modulators (SPPARMα): the next generation of peroxisome proliferator-activated receptor α-agonistsPotential approaches to ameliorate hepatic fat accumulation seen with MTP inhibition.Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity.
P2860
Q24564130-936F52E8-20E0-4505-9589-A69122DC3969Q28071265-FCA96DF1-B40F-4EFA-8F4D-0937DAB080EEQ28539042-C940F142-8A3D-4DE4-A51C-55EC0AA16263Q28539289-4B06C743-AB57-4EC2-BAD1-34F2EF9D2E48Q28543435-C3B87CD8-2176-454F-8E04-B19C72A40C23Q28550623-FBFEF579-1C91-4781-941D-501822C63AF6Q28552063-F576D637-890E-4E85-A2C6-7FD4FF5D1021Q28817618-F79EE86A-D684-40D0-8729-BD4D3B4EECB0Q30251565-A096738D-D884-45DE-9A8E-00B60EB7E894Q30402192-F2A62973-D78D-42C0-B253-28CB796E5B90Q33613330-278EFBB1-1918-48EE-8979-A5CAD31B1BE3Q33815927-2F5AE464-6EF6-4F71-9468-D6EAE4CF2013Q33890230-2C73DC9E-B2F3-4B62-908C-255EE7D3E436Q33913300-8F1939B9-4025-440D-800D-D51AE0FC07C9Q34041838-C67713FC-EB82-4912-8B7C-87C7076165CFQ34185231-73674358-D700-407C-A2A7-151CFEA91FD7Q34401755-34556F26-9566-43AF-8419-0D480A9D5F7BQ34730964-E54F8949-BC56-403D-A22E-6D41D68BF568Q35586085-2550CBC2-4FEB-48BD-BBCC-C89B1205B9D8Q35911451-E4415B02-3E84-49A9-BB6E-4C49246F8190Q35983091-39BE310A-D6F0-4C34-A05E-2FE914B5B7E4Q36011202-3A3221D7-5F52-4E2D-A869-9D560ED5A657Q36253614-7DD518EB-CCD4-4AE3-A3CE-F0D1B8178099Q36334667-A28A5A41-15CD-457D-B218-D57542742610Q36423203-A86DCC78-B851-4564-80D9-AE9E9491C675Q36478196-58988F7E-E567-429B-A500-CD973CEB2B80Q36911049-784D1104-E0D7-45D7-AF62-7ACB80E12C2EQ37062345-EE30C006-8681-4FE9-B65B-BDCE841513DFQ37196514-3AFAA5E9-CF55-4250-8251-38570DE3EF34Q37244257-EAF013E2-4118-44DB-BEF9-1B0FDCB2813EQ37554361-C758ED8E-2097-4D5A-AD5B-0ED4CFEBD15DQ37640263-1A4AC9C5-C271-46D5-AEFA-280D95E55937Q37673273-54CFB8EC-9F3C-4FA3-B35B-7F786DCEC6C8Q37706430-177024A6-6CF7-4166-9D66-BD2E0B35CC8BQ37716350-2312291E-877D-4379-AECE-6C731B6D0E31Q38016858-F9EEDD29-7115-4B77-AA8A-FFE087171E8EQ38018841-FC36D5E6-0C2B-4F7C-A77B-FFA73D7884EBQ38110581-A134E66E-C894-4480-90EA-C1FE28F0A663Q38195808-71616824-D93F-48A2-A491-16216C0F926DQ38197690-003D59D4-8C74-44A8-A257-114D99FE26A2
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Roles of PPARs in NAFLD: potential therapeutic targets.
@en
Roles of PPARs in NAFLD: potential therapeutic targets.
@nl
type
label
Roles of PPARs in NAFLD: potential therapeutic targets.
@en
Roles of PPARs in NAFLD: potential therapeutic targets.
@nl
prefLabel
Roles of PPARs in NAFLD: potential therapeutic targets.
@en
Roles of PPARs in NAFLD: potential therapeutic targets.
@nl
P50
P1476
Roles of PPARs in NAFLD: potential therapeutic targets.
@en
P304
P356
10.1016/J.BBALIP.2011.10.016
P407
P577
2011-10-25T00:00:00Z